More PRNewswire
View Older Stories View Newer Stories-
MCAP Inc. Reports Fourth Quarter 2024 EPS of $0.15 Per Share
-
Keystone Cement Transitions from GCHI to Independent Operations
-
Dutch Bros® New Drink is a Big Dill
-
Financial Finesse's Financial Coaching Platform Wins Again for Technology Innovation
-
Iron Prairie Ventures Launches Fund to Capitalize on America's Reindustrialization
-
Jones Soda Reports Fourth Quarter and Full Year 2024 Results
-
Calamos Announces Upside Cap Rates for CPSP and CPRA: Structured Protection ETFs Providing Exposure to S&P 500 and Russell 2000 with 100% Downside Protection Over One Year
-
Zimmer Biomet Receives CE Mark Approval for RibFix Advantage® Fixation System
-
Bernhard Capital-Backed Delta Utilities Completes Acquisition of CenterPoint Energy's Natural Gas Distribution Businesses in Louisiana and Mississippi
-
Graphic Packaging Holding Company to Close Middletown, Ohio Paperboard Manufacturing Facility
-
W. P. Carey Provides Business Update
-
Conagra Brands Collaborates with Bloom Energy to Utilize Fuel Cell Technology at its Ohio Production Facilities
-
Alfa Laval's annual and sustainability report for 2024 published
-
InteliChart Ranked #1 Patient Engagement Platform by Black Book Research for Third Consecutive Year
-
ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
Brennan Promotes Sarah O' Halloran To Director of Operations
-
ixlayer and Ipsos' "ixInsights 2025" Study Reveals Consumer Expectations for Digital Health and Pharma's Role in Enhancing Patient Experience
-
Veeva Announces Research Site Clinical Trial Management System
-
Huggies® Introduces The Poop Poncho for Parents Who Wish They Had Huggies
-
Meet vívoactive 6, the latest health and fitness smartwatch from Garmin
-
Pickle Juice® Unveils Lefty™: The Ultimate Beverage for Left-Handed Athletes
-
Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia
-
Crestview Partners Closes Continuation Fund for Two Fund III Investments With Nearly $600 Million of Commitments
-
MikeWorldWide Expands Global Presence with New Office in Mexico City
-
Scodix Announces Record-Breaking 2024: Achieves Profitability and 23% Revenue Growth, Driven by Groundbreaking Technology and Strategic Partnerships
-
MyFBAPrep Named to "Inc. 5000 Regionals: Southeast List" for Third-Consecutive Year
-
TrueBlue Awarded Top Honors for Company Culture and Industry Leadership
-
HONEYWELL ANNUAL SHAREOWNERS MEETING SET FOR MAY 20, 2025
-
CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference
-
ITE MANAGEMENT EXPANDS TRANSPORTATION PORTFOLIO WITH ACQUISITION OF THORA CAPITAL
-
Stream.Security Extends Industry's Only Real-Time Cloud Detection & Response Solution with Trap Technology Designed to Proactively Mitigate Breach Impact in the Cloud
-
EVERSANA Joins Veeva AI Partner Program
-
Smartkem Reports Fourth Quarter and Full Year 2024 Financial Results
-
ESTEVE signs a licensing agreement for a severe primary insulin-like growth factor 1 deficiency treatment
-
ITURAN TO PRESENT AT THE LD MICRO INVITATIONAL XV
-
GenOx Transportation's Partnership with ESMART Has Proven to Strengthen Fleet Safety and Prevent Incidents
-
Canadian Solar and Flow Power to Install Innovative Anti-Hail Solar Panels
-
Policy Reporter by Mercalis and AccessSync Announce Strategic Partnership to Transform Market Access Capabilities
-
Adcendo ApS Announces Changes in Board of Directors and Strengthens Executive Leadership Team
-
Corra Group Expands Services to Include Paperless Electronic I-9s as Trump Administration Policies Increase I-9 Audits and Penalties
-
Clear Channel Outdoor Holdings, Inc. Announces Date for 2025 First Quarter Earnings Release and Conference Call
-
Data Showcasing ALZpath's Proprietary pTau217 Antibody at AD/PD™ 2025 Demonstrates High Rate of Reliability and Scalability for Alzheimer's Disease Research and Diagnosis
-
LightInTheBox Files 2024 Annual Report on Form 20-F
-
Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)
-
HONEYWELL APPOINTS STEPHEN WILLIAMSON TO BOARD OF DIRECTORS
-
Informativ Recognized as One of the Fastest-Growing Private Companies in the Southwest by Inc. Magazine
-
Lemon Seed Marketing launches The Great American Brand Story
-
Amwins and Nelligan Join Forces to Expand Ancillary Benefit Offerings
-
ST Engineering iDirect Launches New Excelerator Partner Program
-
LIPTON Teas and Infusions Taps Papaya Global For Payroll and Cross-Border Payments Across 20+ Countries
